Cargando…

CD4(+)CD25(+) T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion

CD4(+)CD25(+) T regulatory cells (Tregs) prevent autoimmune disease, yet little is known about precisely where they exert their influence naturally in a spontaneous autoimmune disorder. Here, we report that Tregs and T effector cells (Teffs) coexist within the pancreatic lesion before type 1 diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Herman, Ann E., Freeman, Gordon J., Mathis, Diane, Benoist, Christophe
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211778/
https://www.ncbi.nlm.nih.gov/pubmed/15184501
http://dx.doi.org/10.1084/jem.20040179
_version_ 1782148552043003904
author Herman, Ann E.
Freeman, Gordon J.
Mathis, Diane
Benoist, Christophe
author_facet Herman, Ann E.
Freeman, Gordon J.
Mathis, Diane
Benoist, Christophe
author_sort Herman, Ann E.
collection PubMed
description CD4(+)CD25(+) T regulatory cells (Tregs) prevent autoimmune disease, yet little is known about precisely where they exert their influence naturally in a spontaneous autoimmune disorder. Here, we report that Tregs and T effector cells (Teffs) coexist within the pancreatic lesion before type 1 diabetes onset. We find that BDC2.5 T cell receptor transgenic animals contain a small subset of FoxP3 positive CD4(+)CD25(+)CD69(−) cells in the pancreas, actively turning over, expressing the clonotypic receptor, and containing functional regulatory activity. Gene expression profiling confirms that the CD4(+)CD25(+)CD69(−) cells in pancreatic tissue express transcripts diagnostic of regulatory cells, but with significantly higher levels of interleukin 10 and inducible costimulator (ICOS) than their lymph node counterparts. Blockade of ICOS rapidly converts early insulitis to diabetes, which disrupts the balance of Teffs and Tregs and promotes a very broad shift in the expression of the T regulatory–specific profile. Thus, CD4(+)CD25(+)69(−) Tregs operate directly in the autoimmune lesion and are dependent on ICOS to keep it in a nondestructive state.
format Text
id pubmed-2211778
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-22117782008-03-11 CD4(+)CD25(+) T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion Herman, Ann E. Freeman, Gordon J. Mathis, Diane Benoist, Christophe J Exp Med Article CD4(+)CD25(+) T regulatory cells (Tregs) prevent autoimmune disease, yet little is known about precisely where they exert their influence naturally in a spontaneous autoimmune disorder. Here, we report that Tregs and T effector cells (Teffs) coexist within the pancreatic lesion before type 1 diabetes onset. We find that BDC2.5 T cell receptor transgenic animals contain a small subset of FoxP3 positive CD4(+)CD25(+)CD69(−) cells in the pancreas, actively turning over, expressing the clonotypic receptor, and containing functional regulatory activity. Gene expression profiling confirms that the CD4(+)CD25(+)CD69(−) cells in pancreatic tissue express transcripts diagnostic of regulatory cells, but with significantly higher levels of interleukin 10 and inducible costimulator (ICOS) than their lymph node counterparts. Blockade of ICOS rapidly converts early insulitis to diabetes, which disrupts the balance of Teffs and Tregs and promotes a very broad shift in the expression of the T regulatory–specific profile. Thus, CD4(+)CD25(+)69(−) Tregs operate directly in the autoimmune lesion and are dependent on ICOS to keep it in a nondestructive state. The Rockefeller University Press 2004-06-07 /pmc/articles/PMC2211778/ /pubmed/15184501 http://dx.doi.org/10.1084/jem.20040179 Text en Copyright © 2004, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Herman, Ann E.
Freeman, Gordon J.
Mathis, Diane
Benoist, Christophe
CD4(+)CD25(+) T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion
title CD4(+)CD25(+) T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion
title_full CD4(+)CD25(+) T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion
title_fullStr CD4(+)CD25(+) T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion
title_full_unstemmed CD4(+)CD25(+) T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion
title_short CD4(+)CD25(+) T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion
title_sort cd4(+)cd25(+) t regulatory cells dependent on icos promote regulation of effector cells in the prediabetic lesion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211778/
https://www.ncbi.nlm.nih.gov/pubmed/15184501
http://dx.doi.org/10.1084/jem.20040179
work_keys_str_mv AT hermananne cd4cd25tregulatorycellsdependentonicospromoteregulationofeffectorcellsintheprediabeticlesion
AT freemangordonj cd4cd25tregulatorycellsdependentonicospromoteregulationofeffectorcellsintheprediabeticlesion
AT mathisdiane cd4cd25tregulatorycellsdependentonicospromoteregulationofeffectorcellsintheprediabeticlesion
AT benoistchristophe cd4cd25tregulatorycellsdependentonicospromoteregulationofeffectorcellsintheprediabeticlesion